Plunkett Research Online: BioSpecifics Technologies Corp

BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of injectable collagenase clostridium histolyticum (CCH) for multiple indications. The firm has a development and license agreement with Endo International plc for injectable collagenase, named XIAFLEX, for c.....


BIOSPECIFICS TECHNOLOGIES CORP

Ticker: BSTC
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 516-593-7000
Fax: 516-593-7039
Address: 35 Wilbur St.
Lynbrook, NY 11563 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Ronald Law CEO
Patrick Caldwell CFO/Chief Accounting Officer
See More
BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of injectable collagenase clostridium histolyticum (CCH) for multiple indications. The firm has a development and license agreement with Endo International plc for injectable collagenase, named XIAFLEX, for c.....See More See More

$USD, In whole numbers 2019 2018 2017 2016 2015 2014 2013
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture